Article Per Year (5 Year)
p-Index From 2021 - 2026
0.444
P-Index
This Author published in this journals
All Journal Jurnal Farmasi Indonesia IJECS: Indonesian Journal of Empowerment and Community Services
Qarriy 'Aina Urfiyya
Unknown Affiliation
Religion Humanities Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Education Health Professions Immunology & microbiology Medicine & Pharmacology Public Health Social Sciences

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
EDUKASI DIABETES MELLITUS SEBAGAI UPAYA MENURUNKAN PREVALENSI PENYAKIT DEGENERATIF Mexsi Mutia Rissa; Qarriy 'Aina Urfiyya
IJECS: Indonesian Journal of Empowerment and Community Services Vol. 4 No. 2 (2023): IJECS: Indonesian Journal of Empowerment and Community Services
Publisher : Universitas Veteran Bangun Nusantara

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.32585/ijecs.v4i2.3418

Abstract

Kesehatan merupakan salah satu faktor penting dalam kehidupan agar seseorang dapat beraktivitas setiap harinya. Banyak masyarakat yang belum menyadari pentingnya kesehatan sehingga seringkali masih ditemukan masalah-masalah kesehatan di masyarakat diantaranya Diabetes Militus dimana suatu sindroma yang ditandai dengan peningkatan kadar glukosa darah disebabkan adanya penurunan sekresi insulin. Faktor resiko dan cepat lambatnya seseorang terkena diabetes mellitus dipengaruhi oleh riwayat keluarga, umur, obesitas, kurang olahraga, gaya hidup, pola makan, merokok, stress. Tujuan kegiatan pengabdian masyarakat ini adalah untuk meningkatkan pengetahuan masyarakat tentang penyakit diabetes mellitus sebagai upaya pencegahan. Pengabdian kepada masyarakat yang dilakukan di Dusun Kepek, RT 06 Timbulharjo, Kecamatan Sewon, Kabupaten Bantul, DI Yogyakarta. Masyarakat yang dijadikan sasaran dalam kegiatan ini adalah ibu ibu PKK berjumlah 44 orang. Metode yang digunakan yaitu ceramah dengan menggunakan media power point, leaflet dan poster. Hasil penyuluhan tentang edukasi diabetes mellitus menunjukkan hasil yang positif, dimana terjadi peningkatan pengetahuan masyarakat terhadap penyakit diabetes.
POTENSI INTERAKSI ANTIDIABETIK ORAL PADA PASIEN RAWAT JALAN DIABETES MELITUS TIPE 2 DI RUMAH SAKIT PKU MUHAMMADIYAH YOGYAKARTA Qarriy 'Aina Urfiyya; Ai Syah
Jurnal Farmasi Indonesia Vol 22 No 2 (2025): Jurnal Farmasi Indonesia
Publisher : Fakultas Farmasi Universitas Setia Budi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.31001/jfi.v22i2.1820

Abstract

Indonesia is ranked fifth with the highest number of Diabetes Mellitus (DM) patients in theworld, with 19.5 million patients in 2021, and is estimated to be 28.6 million in 2045. DMpatients can experience comorbidities and complications, so they are at risk ofpolypharmacy and drug interactions. The average number of drugs for DM patients is 8.9drugs per day and 38.8% have the potential to experience interactions. The purpose of thisstudy was to determine the potential incidence of oral antidiabetic interactions in theprescription of type 2 DM patients. The study used an observational design.The sample wasa prescription for outpatient type 2 DM patients at PKU Muhammadiyah Yogyakarta in theperiod October 2021 - March 2022, totaling 112 prescription sheets. Data analysis used chisquare test on SPSS ver. 23 to see the relationship between the number of drugs andpotential interactions. Drug interaction evaluation was based on drugs.com,go.drugbank.com and Drug Interaction Facts by Tatro (2009). The study showed that thehighest comorbidity was hypertension (25%) and the highest use of oral antidiabetics wasmetformin (45.9%). Potential oral antidiabetic interactions were identified in 52prescriptions out of 112 prescription sheets, with the highest percentage being theinteraction of metformin with furosemide (16%). There was a significant associationbetween the number of drugs prescribed and the incidence of potential oral antidiabeticinteractions (p=0.000). Type 2 DM patients who receive polypharmacy have a greaterpotential for drug interactions.
Co-Authors Ai Syah Mexsi Mutia Rissa